3D 'lung-on-a-chip' model developed to test new therapies fo

3D 'lung-on-a-chip' model developed to test new therapies for COVID-19 and other lung conditions


Allows researchers to study effects of COVID-19 on cell growth and development
Provides insight as to how various drugs impact viral spread
Globally, lung failure is one of the leading causes of death. Many conditions can affect and damage the lungs, including asthma, chronic obstructive pulmonary disease, influenza, pneumonia, and, most recently, COVID-19. To better understand respiratory diseases and develop new drugs faster, investigators from Brigham and Women's Hospital designed a 3D "lung-on-a-chip" model of the distal lung and alveolar structures, the tiny air sacs that take in oxygen as you breathe. With this innovation, researchers are actively studying how COVID-19 viral particles travel through airways and impact pulmonary cells. Notably, this technology enables scientists to investigate how various COVID-19 therapies, such as remdesivir, impact the replication of the virus. Their results are published in

Related Keywords

, European Union Horizon , Brigham Research Institute , Proceedings Of The National Academy Sciences , American Fund For Alternatives To Animal Research , Brigham Department Of Medicine , Vivisection Society , Division Of Engineering , National Academy , New England Anti Vivisection Society , American Fund , Animal Research , European Union , Sciences United States , ஐரோப்பிய தொழிற்சங்கம் அடிவானம் , ப்ரிகாம் ஆராய்ச்சி நிறுவனம் , வைவீஸக்ஶந் சமூகம் , பிரிவு ஆஃப் பொறியியல் , தேசிய கலைக்கழகம் , புதியது இங்கிலாந்து எதிர்ப்பு வைவீஸக்ஶந் சமூகம் , அமெரிக்கன் நிதி , விலங்கு ஆராய்ச்சி , ஐரோப்பிய தொழிற்சங்கம் , அறிவியல் ஒன்றுபட்டது மாநிலங்களில் ,

© 2025 Vimarsana